Lupin Ltd

LUPIN

Company Profile

  • Business description

    Lupin Ltd is a specialty and generic drug manufacturing company. The company produces, develops, and markets branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) globally. It has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, GastroIntestinal, and other drug therapy segments. The operations of the company are limited to the segments, namely pharmaceuticals which derives key revenue, and others. It also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India, and other countries.

  • Contact

    Off. Western Express Highway
    3rd floor, Kalpataru Inspire
    Santacruz (East)
    MumbaiMH400055
    IND

    T: +91 2266402323

    E: [email protected]

    https://www.lupin.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    24,006

Stocks News & Analysis

stocks

Investors cheer Guzman dialing back global ambitions

Our view after US restaurants are closed.
stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.
stocks

Poor organic growth obscured by acquisition for ASX listed share

Sales dropped by 2% without impact of acquisition.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,882.6020.50-0.23%
CAC 408,173.1185.15-1.03%
DAX 4025,184.89204.21-0.80%
Dow JONES (US)50,391.21188.49-0.37%
FTSE 10010,491.3925.130.24%
HKSE25,599.456.58-0.03%
NASDAQ26,602.54258.570.98%
Nikkei 22564,996.09162.10-0.25%
NZX 50 Index13,069.7499.460.77%
S&P 5007,511.8838.410.51%
S&P/ASX 2008,657.8018.80-0.22%
SSE Composite Index4,145.377.20-0.17%

Market Movers